Straits Times Index
3,332.75 +1.94 (+0.06%) Nikkei
38,683.93 -19.58 (-0.05%) Hang Seng
18,373.98 -102.82 (-0.56%) FTSE 100
8,278.02 -7.32 (-0.09%) Bitcoin USD
71,199.89 +292.91 (+0.41%) CMC Crypto 200
1,485.60 +6.90 (+0.47%)
EW Jan 2026 115.000 call
- Zacks
BD (BDX) Inks Buyout Deal to Expand Smart Connected Care Suite
BD's (BDX) latest agreement is likely to unlock new future value-creation opportunities and expand its portfolio of smart connected care solutions.
- Business Wire
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
NEW YORK, June 05, 2024--Edwards Lifesciences (NYSE: EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small annulus. Through five-year follow up of more than 1,300 low and intermediate risk SAPIEN 3 valve patients there were excellent clinical outcomes and valve durability irrespective of the patient’s annulus size or sex. These data were presented during the late-breaking clinical
- Simply Wall St.
Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
